CEACAM5 and esophageal squamous cell carcinoma: One study found that [56] in patients with ESCC who had undergone surgical treatment, the elevation of serum CEA during the postoperative reexamination had some value in predicting the increased risk of postoperative recurrence and distant metastasis, which could assist clinical diagnosis.